← Eichor
Study identifier: NCT05728840 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Virtual-reality Exercises for Alleviating Attention Deficits in Patients With Acquired Brain Injury

Condition: Stroke · Attention Disorder  ·  Sponsor: Mindmaze SA

PhaseNA
Planned participants135
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Stroke is the leading cause of long-term disability with an increasing incidence, especially in young adults. Among the cognitive difficulties following brain damage, deficits in attention are frequent and pervasive, affecting between 46% and 92% of stroke survivors. The current project targets patients with acquired brain injury, including stroke, traumatic brain injury, and brain tumor. The main objective of this study is to evaluate the use and the efficacy of a training program targeting attention and executive function difficulties, using gamified and digitized versions in virtual reality of standard cognitive exercises for patients with brain lesions.

This description comes directly from the study's public registry record.

Talk to the study team

Sonia Crottaz-Herbette  ·  +41213149348  ·  sonia.crottaz-herbette@chuv.ch

Always discuss trial participation with your own doctor first.

Locations (1)

University of Lausanne HospitalsLausanne, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05728840